Conscience Announces Support for Two Projects Advancing Earlier Diagnosis and Treatment of Childhood Rare Diseases
CureSPG50 and SickKids to pursue Phase 1/2 clinical trial of potential gene therapy for CLN7 Batten disease in Canada ThinkRare to expand AI-driven approach to help identify children with undiagnosed rare genetic diseases TORONTO — Conscience, a Canadian non-profit dedicated to enabling drug discovery through open science and collaboration for the advancement of accessible treatments, […]
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
